Target intelligence / Profile preview

CRLF3 pseudogene 2 (CRLF3P2)

Target
CRLF3P2
Molecular classification
Other (pseudogene; not a receptor, enzyme, transporter, etc.)
01

Overview

CRLF3 pseudogene 2 (CRLF3P2) is a genomically annotated pseudogene related to the cytokine receptor-like factor 3 gene (CRLF3). Unlike CRLF3, which encodes a protein involved in neural and hematopoietic cell development and immune regulation, CRLF3P2 does not produce a functional protein and is not implicated in known physiological or disease processes. Pseudogenes such as CRLF3P2 result from gene duplication/recombination events and often lack transcriptional activity or open reading frames necessary for protein coding. There is no documentation of CRLF3P2 functioning as a therapeutic target, biomarker, or having any disease role in current scientific literature[1][2][3][4].\n\nClarification: The biologically and therapeutically relevant gene is CRLF3 (Cytokine receptor-like factor 3), not CRLF3P2. CRLF3 is a receptor-like protein involved in neurobiology and hematopoiesis, and may have roles in disease and tissue protection[1][2][3][4], while CRLF3P2 refers specifically to a nonfunctional pseudogene.\n\nIf molecular target information is required, it's recommended to refer to the canonical functional gene: Cytokine receptor-like factor 3 (CRLF3).

02

Mechanism of action

None (no mechanism of action for drugs, as it is not a target)

03

Biological functions

None (pseudogenes do not generally have known biological functions, unless specified as regulatory noncoding RNAs, which has not been demonstrated for CRLF3P2)
04

Disease associations

None (no evidence supports a direct disease association with CRLF3P2; literature on CRLF3 relates to functional gene, not pseudogenes[1][2][3][4])
05

Safety considerations

None (pseudogenes generally pose no direct safety concerns or therapeutic challenges)
06

Interacting drugs

None (no drugs interact with CRLF3P2; drug studies focus on functional CRLF3)
07

Biomarkers

None (not used as biomarker for disease or therapy)

Beyond the preview

Go deeper on CRLF3 pseudogene 2 (CRLF3P2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on CRLF3 pseudogene 2 (CRLF3P2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call